FAUN PHARMA AS

1543 VESTBY

Finances

Share Ownership

Return on Equity

9,34 %

Current Ratio

3,06

Debt-to-Equity Ratio

0,47

Key figures (NOK)	2022	2021	2020	2019
Revenue	139 952 000	162 132 000	152 958 000	94 084 000
Net Income	2 196 000	9 429 000	9 569 000	2 261 000
Total Assets	45 605 000	39 288 000	39 086 000	27 268 000
Total Equity	23 515 000	21 319 000	11 890 000	2 320 000

Income (NOK)	2022	2021	2020	2019
Revenue	139 952 000	162 132 000	152 958 000	94 084 000
Expenditure	136 837 000	150 940 000	143 031 000	91 223 000
Operating Profit	3 114 000	11 192 000	9 927 000	2 861 000
Financial Income	0	0	0	4 000
Financial Costs	285 000	336 000	358 000	604 000
Financial Balance	−285 000	−336 000	−358 000	−600 000
Earnings Before Tax	2 829 000	10 855 000	9 569 000	2 261 000
Tax	634 000	1 426 000	0	0
Net Income	2 196 000	9 429 000	9 569 000	2 261 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	11 514 000	7 371 000	3 646 000	2 822 000
Total Current Assets	34 091 000	31 917 000	35 440 000	24 447 000
Total Assets	45 605 000	39 288 000	39 086 000	27 268 000
Total Retained Equity	18 156 000	15 960 000	6 531 000	−3 038 000
Total Equity	23 515 000	21 319 000	11 890 000	2 320 000
Total Long-Term Debt	10 943 000	3 993 000	9 213 000	15 946 000
Total Current Debt	11 147 000	13 976 000	17 983 000	9 002 000
Total Equity and Debt	45 605 000	39 288 000	39 086 000	27 268 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	139 658 000	161 928 000	152 655 000	94 034 000
Other Income	294 000	204 000	303 000	50 000
Revenue	139 952 000	162 132 000	152 958 000	94 084 000
Cost of Goods Sold	97 162 000	112 015 000	106 176 000	63 700 000
Salary Costs	26 516 000	25 847 000	24 777 000	17 448 000
Depreciation	1 290 000	814 000	605 000	477 000
Impairment	0	0	0	0
Expenditure	136 837 000	150 940 000	143 031 000	91 223 000
Operating Profit	3 114 000	11 192 000	9 927 000	2 861 000
Financial Income	0	0	0	4 000
Financial Costs	285 000	336 000	358 000	604 000
Financial Balance	−285 000	−336 000	−358 000	−600 000
Dividends	0	0	0	0
Net Income	2 196 000	9 429 000	9 569 000	2 261 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	9 880 000	6 315 000	2 827 000	2 168 000
Fixtures	1 634 000	1 056 000	819 000	654 000
Total Tangible Assets	11 514 000	7 371 000	3 646 000	2 822 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	11 514 000	7 371 000	3 646 000	2 822 000
Stock	26 153 000	17 332 000	22 659 000	13 264 000
Total Investments	0	0	0	0
Cash, Bank	1 745 000	5 931 000	743 000	903 000
Total Current Assets	34 091 000	31 917 000	35 440 000	24 447 000
Total Assets	45 605 000	39 288 000	39 086 000	27 268 000
Total Equity	23 515 000	21 319 000	11 890 000	2 320 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	10 943 000	3 993 000	9 213 000	15 946 000
Creditors	5 410 000	7 710 000	12 493 000	4 129 000
Unpaid Taxes	1 728 000	1 584 000	1 361 000	1 032 000
Dividends	0	0	0	0
Other Current Debt	3 594 000	3 466 000	4 129 000	3 841 000
Total Current Debt	11 147 000	13 976 000	17 983 000	9 002 000
Total Equity and Debt	45 605 000	39 288 000	39 086 000	27 268 000

Financial indicators	2022	2021	2020	2019
Return on Equity	9,34 %	44,23 %	80,48 %	97,46 %
Debt-to-Equity Ratio	0,47	0,19	0,77	6,87
Operating Profit Margin	2,23 %	6,9 %	6,49 %	3,04 %
Current Ratio	3,06	2,28	1,97	2,72
Quick Ratio	−2,27	−9,51	−7,58	−5,74
Equity Ratio	0,52	0,54	0,3	0,09
Gross Profit Margin	30,57 %	30,91 %	30,58 %	32,29 %